Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 5, 2001, Pages 647-652

  Katz, P O ^a   Xue, S ^a   Castell, D O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; THERAPEUTIC EQUIVALENCY;

EID: 0035035380     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00967.x     Document Type: Article

References (17)

1. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis
2. Rapid symptom relief in reflux oesophagitis: A comparison of lansoprazole and omeprazole
3. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis
4. Lansoprazole versus omeprazole in the treatment of reflux esophagitis
5. Appropriate acid suppression for management of gastro-oesophageal reflux disease
6. Role of acid and duodenogastroeophageal reflux in gastroesophageal reflux disease
7. Gastroesopahgeal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors
8. Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects
9. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers
10. The effects of oral doses of lansoprazole and omeprazole on gastric pH
11. Dose-response comparison of lansoprazole and omeprazole on 24-hour gastric acidity and plasma gastrin in healthy
12. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers
13. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastoesophageal reflux in patients with gastroesophageal reflux disease
14. Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial) Dutch Study Group
15. Healing and relapse of severe peptic esophagitis after treatment with omeprazole